Danaher Co. (NYSE:DHR) was the recipient of some unusual options trading activity on Wednesday. Investors acquired 11,962 put options on the company. This is an increase of approximately 1,952% compared to the typical daily volume of 583 put options.

NYSE:DHR opened at $124.88 on Thursday. Danaher has a one year low of $94.59 and a one year high of $134.50. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.07 and a current ratio of 1.47. The stock has a market cap of $91.74 billion, a P/E ratio of 27.63, a price-to-earnings-growth ratio of 2.39 and a beta of 1.04.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, January 29th. The conglomerate reported $1.28 EPS for the quarter, topping the consensus estimate of $1.27 by $0.01. Danaher had a net margin of 13.33% and a return on equity of 11.64%. The business had revenue of $5.40 billion for the quarter, compared to analyst estimates of $5.33 billion. During the same quarter in the previous year, the firm posted $1.19 earnings per share. Danaher’s quarterly revenue was up 6.2% on a year-over-year basis. Research analysts anticipate that Danaher will post 4.79 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Friday, March 29th will be issued a $0.17 dividend. The ex-dividend date is Thursday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.16. This represents a $0.68 annualized dividend and a yield of 0.54%. Danaher’s payout ratio is 15.04%.

Several equities research analysts recently commented on DHR shares. Janney Montgomery Scott boosted their price objective on shares of Danaher from $136.00 to $174.00 and gave the stock a “buy” rating in a research note on Wednesday. Needham & Company LLC reissued a “buy” rating and set a $141.00 price objective (up previously from $138.00) on shares of Danaher in a research note on Wednesday. Zacks Investment Research raised shares of Danaher from a “hold” rating to a “buy” rating and set a $147.00 price objective on the stock in a research note on Tuesday, April 9th. Cowen reissued a “buy” rating and set a $110.00 price objective on shares of Danaher in a research note on Monday, January 7th. Finally, Deutsche Bank boosted their price objective on shares of Danaher to $130.00 and gave the stock a “buy” rating in a research note on Tuesday, February 26th. One research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. Danaher presently has an average rating of “Buy” and an average price target of $129.14.

In other news, EVP Daniel L. Comas sold 97,357 shares of Danaher stock in a transaction dated Wednesday, February 27th. The shares were sold at an average price of $127.04, for a total transaction of $12,368,233.28. Following the sale, the executive vice president now owns 134,039 shares of the company’s stock, valued at approximately $17,028,314.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Rainer Blair sold 37,859 shares of Danaher stock in a transaction dated Wednesday, February 27th. The shares were sold at an average price of $127.45, for a total transaction of $4,825,129.55. Following the sale, the insider now directly owns 32,661 shares in the company, valued at approximately $4,162,644.45. The disclosure for this sale can be found here. Insiders have sold a total of 183,150 shares of company stock worth $23,279,637 in the last ninety days. Insiders own 11.40% of the company’s stock.

A number of institutional investors have recently modified their holdings of DHR. Norges Bank purchased a new position in Danaher in the fourth quarter worth about $747,082,000. Oregon Public Employees Retirement Fund raised its holdings in Danaher by 10,085.3% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 6,863,048 shares of the conglomerate’s stock worth $67,000 after buying an additional 6,795,666 shares during the last quarter. Findlay Park Partners LLP raised its holdings in Danaher by 25.0% in the fourth quarter. Findlay Park Partners LLP now owns 4,595,000 shares of the conglomerate’s stock worth $473,836,000 after buying an additional 920,000 shares during the last quarter. 1832 Asset Management L.P. raised its holdings in Danaher by 74.3% in the fourth quarter. 1832 Asset Management L.P. now owns 2,129,142 shares of the conglomerate’s stock worth $219,310,000 after buying an additional 907,593 shares during the last quarter. Finally, AQR Capital Management LLC raised its holdings in shares of Danaher by 48.2% during the third quarter. AQR Capital Management LLC now owns 2,682,662 shares of the conglomerate’s stock valued at $291,498,000 after purchasing an additional 872,626 shares during the last quarter. 77.59% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: This article was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another publication, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this article can be read at https://www.thecerbatgem.com/2019/04/18/traders-buy-large-volume-of-put-options-on-danaher-dhr.html.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Featured Story: How to calculate compound interest

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.